Thromb Haemost 1981; 46(01): 189
DOI: 10.1055/s-0038-1652542
Coagulation – XIII: Factor VIII, Carrier Detection, Antibody
Coagulation – XIV: Factor VIII, Treatment, Antibodies
Schattauer GmbH Stuttgart

Increased Circulating Immune Complex Levels In Hemophilia Patients Post-Infusion

M W Hilgartner
Department of Pediatrics, New York Hospital-Cornell University Medical Center and Division of Rheumatology, Hospital for Special Surgery, New York, N.Y. U.S.A.
,
R D Inman
Department of Pediatrics, New York Hospital-Cornell University Medical Center and Division of Rheumatology, Hospital for Special Surgery, New York, N.Y. U.S.A.
,
C H Miller
Department of Pediatrics, New York Hospital-Cornell University Medical Center and Division of Rheumatology, Hospital for Special Surgery, New York, N.Y. U.S.A.
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Preview

Elevated levels of circulating immune complexes (CIC) have been reported in a significant proportion of hemophilia patients tested by Raji cell, Clq binding, and staphylococcal binding (SBA) methods. The clinical significance of these complexes is unclear, as is their relationship to transfused material. By SBA, we found elevated CIC levels (>10 ug/ml) in 90% of severe hemophiliacs and 75% of multiply-transfused controls, all more than 72 hours post-transfusion. This was in contrast to our previous finding elevated CIC in 50% of hemophiliacs and 29% of controls by Raji cell assay.

Using the SBA, seven patients were tested at intervals after Factor VIII concentrate infusion. Five showed increased CIC levels. The peak level occurred after the Factor VIII clotting activity had peaked and was declining. Two subjects showed rapid clearance of the complexes, while the others remained elevated at 24 hours. Factor VIII-related antigen was detected in isolated complexes from 2 patients. Our previous finding of HBsAg in such complexes suggests heterogeneity and perhaps different clearance patterns.